1XI7

NMR structure of the carboxyl-terminal cysteine domain of the VHv1.1 polydnaviral gene product

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	1mM C-term VHv1.1, 25mM phosphate buffer, 100mM NaCl, 1mM EDTA, 0.01% sodium azide	95% H2O/5% D2O	100mM NaCl	5.7	ambient	310
2	2D TOCSY	1mM C-term VHv1.1, 25mM phosphate buffer, 100mM NaCl, 1mM EDTA, 0.01% sodium azide	95% H2O/5% D2O	100mM NaCl	5.7	ambient	310
3	DQF-COSY	1mM C-term VHv1.1, 25mM phosphate buffer, 100mM NaCl, 1mM EDTA, 0.01% sodium azide	95% H2O/5% D2O	100mM NaCl	5.7	ambient	310

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	600

NMR Refinement
Method	Details	Software
torsion angle dynamics & simulated annealing protocol using the CNS program		XWINNMR

NMR Ensemble Information
Conformer Selection Criteria	AVERAGE STRUCTURE
Conformers Calculated Total Number	1
Conformers Submitted Total Number	1
Representative Model	1 (minimized average structure)

Additional NMR Experimental Information
Details	This structure was determined using standard 2D proton NMR techniques

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	XWINNMR	2.6	Bruker Inc.
2	structure solution	CNS	1.0	Brunger
3	refinement	CNS	1.0	Brunger

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.